
Inside Hibsago's Approval: A Finite RNA Therapy for Chronic Hepatitis B
Dr. Dereck Mush, MD, MBAGSK is a biopharmaceutical company that researches, makes, and sells specialty medicines, vaccines, and general medicines.
GSK is headquartered in London and was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. Its research and products focus on respiratory disease, immunology and inflammation, oncology, HIV, and infectious diseases. It is one of the largest vaccine makers, with vaccines against shingles, meningitis, RSV, and other infections. Its HIV medicines are sold through ViiV Healthcare, a company majority owned by GSK. The company has research and manufacturing sites in many countries, and its shares trade in London and New York.
Leadership as of 14 November 2026.
Chief Executive Officer

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAMentions GSK
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: